The vanilloid receptor as a putative target of diverse chemicals in multiple chemical sensitivity.

The vanilloid receptor (TRPV1 or VR1), widely distributed in the central and peripheral nervous system, is activated by a broad range of chemicals similar to those implicated in Multiple Chemical Sensitivity (MCS) Syndrome. The vanilloid receptor is reportedly hyperresponsive in MCS and can increase nitric oxide levels and stimulate N-methyl-D-aspartate (NMDA) receptor activity, both of which are important features in the previously proposed central role of nitric oxide and NMDA receptors in MCS. Vanilloid receptor activity is markedly altered by multiple mechanisms, possibly providing an explanation for the increased activity in MCS and symptom masking by previous chemical exposure. Activation of this receptor by certain mycotoxins may account for some cases of sick building syndrome, a frequent precursor of MCS. Twelve types of evidence implicate the vanilloid receptor as the major target of chemicals, including volatile organic solvents (but not pesticides) in MCS.
AuthorsMartin L Pall, Julius H Anderson
JournalArchives of environmental health (Arch Environ Health) Vol. 59 Issue 7 Pg. 363-75 (Jul 2004) ISSN: 0003-9896 [Print] United States
PMID16241041 (Publication Type: Journal Article, Review)
Chemical References
  • TRPV Cation Channels
  • TRPV1 receptor
  • Peroxynitrous Acid
  • Nitric Acid
  • N-Methylaspartate
  • Environmental Exposure (adverse effects)
  • Fungi
  • Humans
  • Multiple Chemical Sensitivity (etiology, metabolism, physiopathology)
  • N-Methylaspartate (biosynthesis)
  • Nitric Acid
  • Peroxynitrous Acid (biosynthesis)
  • Sick Building Syndrome (metabolism, physiopathology)
  • TRPV Cation Channels (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: